| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Alsomairy | 140 | 29% |
| Examiner Chase | 14 | 7% |
| Examiner Cunningchen | 10 | 0% |
| Examiner Gustilo | 6 | 17% |
| Examiner Halvorson | 257 | 43% |
| Examiner Holtzman | 17 | 29% |
| Examiner O'Brien | 1 | 0% |
| Examiner Puttlitz | 577 | 64% |
| Examiner Reddig | 366 | 60% |
| Examiner Sang | 377 | 56% |
| Art Unit 1646 | 1765 | 54% |
| Number | Class Description |
|---|---|
| 424 | Drug, bio-affecting and body treating compositions |
| 514 | Drug, bio-affecting and body treating compositions |
| 435 | Chemistry: molecular biology and microbiology |
| 530 | Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof |
| 506 | Combinatorial chemistry technology: method, library, apparatus |
| 536 | Organic compounds -- part of the class 532-570 series |
| 436 | Chemistry: analytical and immunological testing |
| 702 | Data processing: measuring, calibrating, or testing |
| 604 | Surgery |
| 800 | Multicellular living organisms and unmodified parts thereof and related processes |
Art Unit 1646's grant rate is lower than that of Group 1640 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1646, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.